麻豆传媒

Over $1 billion of funding has so far failed to bring any new therapies to market

Immunocompromised people and others say they must remain vigilant

Cognitive and behavioral therapy boosted physical function in pragmatic trial

A look back at newsworthy stories of 2024

Researchers observed dose-response relationship for increasing BMI and long COVID risk

No benefit for brain fog or fatigue, but higher doses may have promise

Secondary analysis of trial data consistent with observational studies

Summer waves, long COVID data, and hope on the horizon

While 14 symptoms were common in both groups, differences also emerged

Lab tests can rule out other conditions, but are not biomarkers for long COVID

Some early pandemic patients dropped IQ points and did not return to their jobs

Experts unpack what recent outbreaks mean for public health

However, metabolic and gastrointestinal sequelae increased among the unvaccinated

Overly broad criteria won't help patients in the long run